Name | Number of supported studies | Average coverage | |
---|---|---|---|
GABAergic neuron | 3 studies | 21% ± 4% | |
glutamatergic neuron | 3 studies | 27% ± 6% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 4 studies | 20% ± 5% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
ovary | 100% | 895.67 | 180 / 180 | 100% | 11.01 | 430 / 430 |
prostate | 100% | 795.40 | 245 / 245 | 100% | 8.48 | 502 / 502 |
esophagus | 100% | 764.75 | 1444 / 1445 | 100% | 10.69 | 183 / 183 |
breast | 100% | 873.61 | 459 / 459 | 100% | 12.37 | 1117 / 1118 |
lung | 100% | 686.42 | 577 / 578 | 100% | 12.72 | 1155 / 1155 |
bladder | 100% | 859.05 | 21 / 21 | 100% | 10.07 | 503 / 504 |
uterus | 100% | 1035.20 | 170 / 170 | 100% | 13.19 | 458 / 459 |
brain | 100% | 617.75 | 2636 / 2642 | 100% | 15.51 | 705 / 705 |
stomach | 100% | 666.20 | 359 / 359 | 100% | 8.80 | 285 / 286 |
thymus | 100% | 760.00 | 653 / 653 | 100% | 9.78 | 602 / 605 |
intestine | 100% | 725.36 | 966 / 966 | 99% | 9.18 | 524 / 527 |
pancreas | 99% | 413.54 | 326 / 328 | 100% | 8.32 | 178 / 178 |
skin | 100% | 670.73 | 1809 / 1809 | 99% | 14.15 | 469 / 472 |
kidney | 100% | 525.97 | 89 / 89 | 98% | 7.30 | 886 / 901 |
adrenal gland | 100% | 855.54 | 258 / 258 | 98% | 11.20 | 225 / 230 |
liver | 100% | 452.92 | 226 / 226 | 95% | 5.68 | 387 / 406 |
adipose | 100% | 915.52 | 1204 / 1204 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 7.30 | 29 / 29 |
muscle | 100% | 1793.69 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 703.06 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 11.00 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 4.16 | 1 / 1 |
blood vessel | 100% | 530.31 | 1330 / 1335 | 0% | 0 | 0 / 0 |
heart | 99% | 744.62 | 854 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 96% | 8.47 | 77 / 80 |
peripheral blood | 43% | 219.65 | 403 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0000122 | Biological process | negative regulation of transcription by RNA polymerase II |
GO_0006357 | Biological process | regulation of transcription by RNA polymerase II |
GO_0090575 | Cellular component | RNA polymerase II transcription regulator complex |
GO_0005654 | Cellular component | nucleoplasm |
GO_0071339 | Cellular component | MLL1 complex |
GO_0000785 | Cellular component | chromatin |
GO_0005634 | Cellular component | nucleus |
GO_0000978 | Molecular function | RNA polymerase II cis-regulatory region sequence-specific DNA binding |
GO_0046983 | Molecular function | protein dimerization activity |
GO_0000977 | Molecular function | RNA polymerase II transcription regulatory region sequence-specific DNA binding |
GO_0005515 | Molecular function | protein binding |
GO_0000981 | Molecular function | DNA-binding transcription factor activity, RNA polymerase II-specific |
GO_0001227 | Molecular function | DNA-binding transcription repressor activity, RNA polymerase II-specific |
Gene name | E2F6 |
Protein name | E2F transcription factor 6 (Putative truncated transcription factor E2F6) Transcription factor E2F6 (E2F-6) E2F transcription factor 6, isoform CRA_d (E2F6 splice variant c) (E2F6 splice variant d) (E2F6 splice variant e) (cDNA FLJ38878 fis, clone MESAN2015365, highly similar to TRANSCRIPTION FACTOR E2F6) E2F transcription factor 6 E2F transcription factor 6 isoform 1 (E2F transcription factor 6, isoform CRA_c) E2F6 splice variant f E2F6 splice variant a |
Synonyms | hCG_1989492 |
Description | FUNCTION: Inhibitor of E2F-dependent transcription . Binds DNA cooperatively with DP proteins through the E2 recognition site, 5'-TTTC[CG]CGC-3' . Has a preference for the 5'-TTTCCCGC-3' E2F recognition site . E2F6 lacks the transcriptional activation and pocket protein binding domains . Appears to regulate a subset of E2F-dependent genes whose products are required for entry into the cell cycle but not for normal cell cycle progression . Represses expression of some meiosis-specific genes, including SLC25A31/ANT4 (By similarity). May silence expression via the recruitment of a chromatin remodeling complex containing histone H3-K9 methyltransferase activity. Overexpression delays the exit of cells from the S-phase . . |
Accessions | F8WEZ5 ENST00000307236.8 [O75461-3] ENST00000542100.5 [O75461-2] A0A0S2Z3K8 Q6Q9Z7 ENST00000421117.1 ENST00000444832.5 Q2Z197 ENST00000455198.5 O75461 ENST00000546212.2 [O75461-2] F8WC40 ENST00000428221.5 Q6Q9Z5 Q2Z196 Q53YM3 ENST00000437573.5 ENST00000381525.8 [O75461-1] |